Table 1. Baseline demographic and clinical characteristics of patients.
| Study group (n=67) | |
|---|---|
| Age, years | 32.44±15.74 |
| Sex, % female | 31% |
| Liver grading | |
| 0.5 | 16% |
| 1 | 47.5% |
| 1.5 | 17% |
| 2 | 16% |
| 2.5 | 3.5% |
| Liver staging | |
| 0.5 | 28% |
| 1 | 39% |
| 1.5 | 11% |
| 2 | 14% |
| 2.5 | 5% |
| 3.5 | 3% |
| HBV DNA, kIU/mLa | 12 847±8305 |
| HBsAg, % positive | 100% |
| HBeAg, % positive | 6% |
| anti-HBe, % positive | 71% |
| ALT, IU/L | 31±9.48 |
| AST, IU/L | 25±12 |
| GGT, IU/L | 21±29 |
Abbreviations: alanine aminotransferase, ALT; aspartate aminotransferase, AST; gamma-glutamyl transferase, GGT.
a
Mean value±standard error (SE).
Data are presented as a median value±interquartile range (IQR).